Gout News

Reports of acute renal failure occur 5.7 times more frequently among patients treated with febuxostat, and 3.3 times more often with allopurinol, compared with other drugs, according to data published in Arthritis Research & Therapy.

Although there is no significant difference between naproxen and low-dose colchicine in terms of improvements in pain intensity among patients with gout flare, naproxen causes fewer side effects, making it the superior first-line option for gout flares in primary care, according to findings published in Annals of the Rheumatic Diseases.

Officials from the Nebraska Department of Health and Human Services have issued a public health advisory following multiple reports of serious adverse events in patients who were treated with unapproved stem cell products, particularly those marketed as containing exosomes.

When journalist Ben Hammersley coined the word “podcast” in 2004, he was attempting to put a name to the phenomenon resulting from the timely convergence of widely available MP3 player technology, inexpensive audio software and weblog culture — a renaissance of radio programs that could be downloaded and played at the listener’s convenience, anytime or anywhere.

ATLANTA — Gout is associated with an increased risk for cardiovascular disease, as calculated via population-level cardiovascular risk equations, according to data presented at ACR/ARP 2019.

PHILADELPHIA — Adults with a recent MI were less likely to experience an ischemic CV event over 2 years when assigned the anti-inflammatory gout medication colchicine compared with assignment to placebo, according to new results of the COLCOT trial presented at the American Heart Association Scientific Sessions.

ATLANTA — The 2019 ACR gout guidelines call for treating patients to a target serum urate level of 6 mg/dL, a marked departure from the 2012 document, according to speakers at ACR/ARP 2019.

ATLANTA — Nearly one-third of primary care providers who treat patients with arthritis failed to follow Exercise Is Medicine guidance for physical activity, according to data presented at ACR/ARP 2019.

WASHINGTON — At ASN Kidney Week, Abdul A. Abdellatif, MD, FASN, presented results that assessed the relationship between gout and return to hemodialysis among patients who had a kidney transplant. Researchers found patients who developed gout after transplantation were more likely to need maintenance hemodialysis compared with patients without gout and those with preexisting gout.

WASHINGTON — At ASN Kidney Week, Abdul A. Abdellatif, MD, FASN, presented results of a study on renal transplant patients that found those with gout had increased rates of transplant-related complications.